Hawk® JAWS versus Lumenis® VersaCut prostate morcellation devices: A comparative study and comprehensive literature review

Abstract

Objective: Although morcellation is a standard procedure of Holmium Laser Enucleation of the Prostate (HoLEP), studies on the morcellators used are limited in number. We aimed to compare two different tissue morcellators used in HoLEP, which have similar objectives but differences in efficiency and safety in working principles.
Material and Methods: The data of 130 patients who underwent HoLEP between December 2018 and December 2019 were retrospectively reviewed. Sixty-five patients received Lumenis® Versacut (Lumenis Inc., Santa Clara, CA, USA) morcellator and 65 patients received Hawk® JAWS (Hawk, Minitech Co., China) morcellator after enucleation were included in the study. The efficiency of morcellation (g/min), morcellation time (min), total operation time (min), enucleation time (min), enucleated tissue weight (g), the efficiency of enucleation, densities of the removed prostate tissues, perioperative complications associated with the use of a morcellator were recorded perioperatively.
Results: There was no significant difference in total operation time (min), enucleation time (min), enucleated tissue weight (g), and efficiency of enucleation (g/min) efficiency of morcellation, morcellation time (min) between the two groups. Bladder mucosal damage occurred in 3 patients (4%) in the Versacut group, while mucosal bladder damage was not observed in any patient in the Hawk® JAWS group (p = 0.08).
Conclusion: Hawk® JAWS and Lumenis® VersaCut morcellators were comparable in their efficiency and safety.

Keywords

• Hawk
• HoLEP
• morcellation
• morcellator
• Versacut

Hawk® JAWS ve Lumenis® VersaCut prostat morselasyon cihazları: Karşılaştırmalı bir çalışma ve kapsamlı literatür incelemesi

Abstract

Amaç: Morselasyon, prostatın holmium lazer ile enükleasyonunun (HoLEP) standart bir prosedürü olmasına rağmen, kullanılan morselatorlerle ilgili çalışmalar sınırlı sayıdadır. HoLEP’de kullanılan, benzer amaçlara sahip ancak çalışma prensipleri farklılıkları olan iki farklı doku morselatörünü verimlilik ve güvenlik açısından karşılaştırmayı amaçladık.
Gereç ve Yöntemler: Aralık 2018 ile Aralık 2019 arasında HoLEP uygulanan 130 hastanın verileri retrospektif olarak incelendi. Lumenis® Versacut (Lumenis Inc., Santa Clara, CA, ABD) morselatorün kullanıldığı 65 hasta, Hawk® JAWS (Hawk, Minitech Co., China) morselatorün kullanıldığı 65 hasta çalışmada yer aldı. Morselasyon etkinliği (g / dk), morselasyon süresi (dk), toplam operasyon süresi (dk), enükleasyon süresi (dk), enükle edilen doku ağırlığı (g), enükleasyon etkinliği, çıkarılan prostat dokusu yoğunluğu, perioperatif komplikasyonlar kaydedildi.
Bulgular: İki grup arasında toplam operasyon süresi (dk), enükleasyon süresi (dk), enükleasyon etkinliği (g / dk) morselasyon etkinliği (g / dk), morselasyon süresi (dk) açısından anlamlı bir fark yoktu (p> 0.05). Versacut grubunda 3 hastada (%4) mesane mukoza hasarı meydana gelirken, Hawk® JAWS grubunda mesane mukozal hasarı hiçbir hastada gözlenmedi (p = 0.08).
Sonuç: Hawk® JAWS ve Lumenis® VersaCut morselatorleri, verimlilikleri ve güvenlik profilleri açısından karşılaştırılabilir sonuçlara sahiptir.

Keywords

• Hawk
• HoLEP
• morselasyon
• morselator
• Versacut

References

1. Fraundorfer MR, Gilling PJ. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol. 1998; 33(1):69-72.
2. Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008; 53(1):160-166.
3. Rieken M, Ebinger Mundorff N, Bonkat G, Wyler S, Bachmann A. Complications of laser prostatectomy: a review of recent data. World J Urol. 2010; 28(1):53-62.
4. Vincent MW, Gilling PJ. HoLEP has come of age. World J Urol. 2015; 33(4):487-493.
5. Sivarajan G, Borofsky MS, Shah O, Lingeman JE, Lepor H. The Role of Minimally Invasive Surgical Techniques in the Management of Large-gland Benign Prostatic Hypertrophy. Rev Urol. 2015; 17(3):140-149.
6. Foster HE, Dahm P, Kohler TS, et al. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019. J Urol. 2019; 202(3):592-598.
7. Oelke M, Bachmann A, Descazeaud A, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013; 64(1):118-140.
8. Elshal AM, Mekkawy R, Laymon M, El-Assmy A, El-Nahas AR. Towards optimizing prostate tissue retrieval following holmium laser enucleation of the prostate (HoLEP): Assessment of two morcellators and review of literature. Can Urol Assoc J. 2015; 9(9-10):E618-625.

9. Lee SH, Choi JI, Moon KY, Na W, Lee JB. Holmium laser enucleation of the prostate: modified morcellation technique and results. Korean J Urol. 2012; 53(11):779-784.
10. Becker B, Orywal AK, Hausmann T, Gross AJ, Netsch C. A Prospective Randomized Study Comparing Disposable with Reusable Blades for a Morcellator Device. J Endourol. 2017; 31(3):314-319.
11. Cornu JN, Terrasa JB, Lukacs B. Ex vivo comparison of available morcellation devices during holmium laser enucleation of the prostate through objective parameters. J Endourol. 2014; 28(10):1237-1240.
12. Kaya E, Gazel E, Yalcin S, et al. The effect of prostatic tissue density on the perioperative outcomes of Holmium laser enucleation of prostate (HoLEP): a pilot study. World J Urol. 2020; 38(2):455-461.
13. Tunc L, Yalcin S, Kaya E, et al. The “Omega Sign”: a novel HoLEP technique that improves continence outcomes after enucleation. World J Urol. 2021; 39(1):135-141.
14. Yalçın S, Yılmaz S, Gazel E, et al. Holmium laser enucleation of the prostate for the treatment of size-independent BPH: A single-center experience of 600 cases. Turk J Urol. 2020; 46(3):219-225.
15. Oh SJ. Current surgical techniques of enucleation in holmium laser enucleation of the prostate. Investig Clin Urol. 2019; 60(5):333-342.
16. Taylan E, Sahin C, Zeybek B, Akdemir A. Contained Morcellation: Review of Current Methods and Future Directions. Front Surg. 2017; 4:15.
17. Maheshwari PN, Wagaskar VG, Maheshwari RP. Comparison of the efficiency and complications of Lumenis and Wolf morcellators after holmium laser enucleation of the prostate. Indian J Urol. 2018; 34(2):140-143.
18. Hodhod A, Oquendo F, Nour H, et al. The ex vivo and in vivo Characteristics of New DrillCutTM Prostate Morcellator after Holmium Laser Enucleation of the Prostate: A Pilot Study. Urol Int. 2019; 103(1):95-101.
19. Ibrahim A, Elhilali MM, Elkoushy MA, Andonian S, Carrier S. DrillCut(TM) vs VersaCut(TM) prostate tissue morcellation devices after holmium laser enucleation: A prospective, randomized controlled trial. Can Urol Assoc J. 2018; 13(8):266-270.
20. McAdams S, Nunez-Nateras R, Martin CJ, Cha S, Humphreys MR. Morcellation Efficiency in Holmium Laser Enucleation of the Prostate: Oscillating Morcellator Outperforms Reciprocating Morcellator With no Apparent Learning Curve. Urology. 2017; 106:173-177.
21. Rivera ME, Lingeman JE, Heinsimer K, York NE, Krambeck AE. A Survey of Morcellator Preference and Cost Comparison of the Lumenis VersaCut and Wolf Piranha Morcellators. Urology. 2018; 111:54-58.
22. El Tayeb MM, Borofsky MS, Paonessa JE, Lingeman JE. Wolf Piranha Versus Lumenis VersaCut Prostate Morcellation Devices: A Prospective Randomized Trial. J Urol. 2016; 195(2):413-417.
23. He G, Shu Y, Wang B, et al. Comparison of Diode Laser (980 nm) Enucleation vs Holmium Laser Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: A Randomized Controlled Trial with 12-Month Follow-Up. J Endourol. 2019; 33(10):843-849.
24. Morozov A, Taratkin M, Kozlov V, et al. Retrospective Assessment of Endoscopic Enucleation of Prostate Complications: A Single-Center Experience of More Than 1400 Patients. J Endourol. 2020; 34(2):192-197.
25. Elkoushy MA, Elshal AM, Elhilali MM. Reoperation After Holmium Laser Enucleation of the Prostate for Management of Benign Prostatic Hyperplasia: Assessment of Risk Factors with Time to Event Analysis. J Endourol. 2015; 29(7):797-804.
26. Zhang J, Wang X, Zhang Y, et al. 1470 nm Diode Laser Enucleation vs Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia: A Randomized Study. J Endourol. 2019; 33(3):211-217.
27. Zhang J, Li J, Wang X, et al. Efficacy and Safety of 1470-nm Diode Laser Enucleation of the Prostate in Individuals With Benign Prostatic Hyperplasia Continuously Administered Oral Anticoagulants or Antiplatelet Drugs. Urology. 2020; 138:129-133.